Yıl: 2020 Cilt: 35 Sayı: 3 Sayfa Aralığı: 195 - 201 Metin Dili: İngilizce DOI: 10.5222/MMJ.2020.29964 İndeks Tarihi: 14-06-2021

Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?

Öz:
Objective: To determine the levels of thyroid-stimulating hormone (TSH), thyroxin (T4), triiodothyronine (T3), anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) and renal iodine excretion (RIE) in the first trimester of the pregnancy and to estimate the risk of developingGDM in these patients.Method: The levels of TSH, T3, T4, anti-TPO, anti-TG, and RIE were retrospectively evaluated. Atotal of 312 pregnant women were included in the study (GDM (-) group n=240, GDM (+) groupn=62). Diagnosis of GDM was made according to the recommendation of American DiabetesOrganization (ADA). The association between thyroid dysfunction and GDM was evaluated.Results: Our study included a total of 302 women. Sixty-two of these women were diagnosedas GDM (62/302=20.5%). When compared with the GDM (-) group the mean TSH level (2.02 vs4.13 p=0.019), anti-TPO positivity (8.3% vs 30.64% p=0.044), anti-TG positivity (8.3% vs 19.4%p=0.019) and RIE (156 vs 178 p=0.017) were significantly higher in the GDM (+) group. TSHlevels were statistically significantly higher in patients with positive anti-TPO levels (P=0.045).Conclusion: Elevated TSH levels , TPO and TG antibody positivity rates were more frequentamong the patients with GDM. These results may be a guide to perform routine thyroid functiontests for patients with increased risk of GDM, on the other hand, they will alert the physicians forGDM progression and ensure taking preventive attempts for the patients who have thyroid disorder, especially those with positive thyroid antibodies in the first trimester of the pregnancy
Anahtar Kelime:

Gebelikte Tiroid Fonksiyon Bozuklukları, Tiroid Antikorları ve Gestasyonel Diabetes Mellitus (GDM) Gelişimi Arasında Bir İlişki Var Mıdır?

Öz:
Amaç: Gebeliğin ilk trimesterında tiroid stimule edici hormon (TSH), tiroksin (T3), triiodotironin (T3), anti- tiroid peroksidaz (anti-TPO), anti tiroglobulin (anti-TG) ve renal iyot atılımını (RIA) saptamak ve bu hastalarda gestasyonel diyabet (GDM) gelişme riskini belirlemek. Yöntem: TSH, T3, T4, anti-TPO, anti-TG ve üriner iyot atılımı düzeyleri retrospektif olarak değerlendirildi. Toplamda 302 kadın çalışmaya dahil edildi (GDM (-) grup n=240, GDM (+) grup n=62). GDM tanısı Amerikan Diyabet Derneğinin (American Diabetes Organization (ADA) önerileri doğrultusunda yapıldı. Tiroid disfonksiyonu ve GDM arasındaki ilişki değerlendirildi. Bulgular: Çalışmamıza toplamda 302 kadın dahil edildi. Bu kadınlardan altmış ikisi GDM tanısı aldı (62/302=%20.5). Ortalama TSH düzeyi (2.02 vs 4.13 p=0.019), anti-TPO (8.3% vs 30.64% p=0.044), anti-TG pozitifliği (8.3% vs 19.4% p=0.01) ve RIA düzeyleri (156 vs 178 p=0.017) GDM (+) saptanan grupda anlamlı olarak yüksek saptandı TSH, anti-TPO pozitif olan kadınlarda daha yüksek olma eğiliminde olup, bu fark istatistiksel olarak anlamlı saptandı (P=0.045). Sonuç: Artmış TSH düzeyi ve anti-TPO, TG antikor pozitifliği GDM’li hastalarda daha sık olarak gözlenir. Çalışmamızın sonuçları, artmış GDM riski olan hastalarda rutin tiroid fonksiyon testi ile değerlendirme konusunda yol gösterici olacak, diğer taraftan, gebelikte tiroid fonksiyon bozukluğu, özellikle ilk trimester’da tiroid antikor pozitifliği olan hastalarda GDM gelişimi açısından dikkatli olunması ve önleyici adımların atılması sağlanacaktır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Karakaya BK, Moraloglu O, Findik RB, et al. Evaluation of maternal and fetal stress hormones during the process of birth. Gynecology Obstetrics & Reproductive Medicine. 2018;24:65-70. [CrossRef]
  • 2. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18:404-33. [CrossRef]
  • 3. Krajewski DA, Burman KD. Thyroid disorders in pregnancy. Endocrinol Metab Clin North Am. 2011;40:739-63.
  • 4. Leung AM. Thyroid function in pregnancy. J Trace Elem Med Biol. 2012;26:137-40. [CrossRef]
  • 5. Van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2016;22:532-3. [CrossRef]
  • 6. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315-89. [CrossRef]
  • 7. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91:2587-91. [CrossRef]
  • 8. Abbassi-Ghanavati M, Casey BM, Spong CY, McIntire DD, Halvorson LM, Cunningham FG. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol. 2010;116:381-6. [CrossRef]
  • 9. De Zoysa E, Hettiarachchi M, Liyanage C. Urinary iodine and thyroid determinants in pregnancy: a follow up study in Sri Lanka. BMC Pregnancy Childbirth. 2016;16:303. [CrossRef]
  • 10. Brucker-Davis F, Ferrari P, Gal J, Berthier F, Fenichel P, Hieronimus S. Iodine status has no impact on thyroid function in early healthy pregnancy. J Thyroid Res. 2012;2012:168764. [CrossRef]
  • 11. Kumar A, De Leiva A, Corcoy R. Autoimmunity in Gestational Diabetes Mellitus. Gestational Diabetes. 28: Karger Publishers; 2020; p:234-42. [CrossRef]
  • 12. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):62-9. [CrossRef]
  • 13. Vitacolonna E, Lapolla A, Di Nenno B, et al. Gestational diabetes and thyroid autoimmunity. Int J Endocrinol. 2012;2012:867415. [CrossRef]
  • 14. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011;2011:439463. [CrossRef]
  • 15. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622-7. [CrossRef]
  • 16. Tosi F, Moghetti P, Castello R, Negri C, Bonora E, Muggeo M. Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism. 1996;45:1029-33. [CrossRef]
  • 17. Kahaly GJ, Hansen MP. Type 1 diabetes associated autoimmunity. Autoimmun Rev 2016;15:644-8. [CrossRef]
  • 18. Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003;26:1181-5. [CrossRef]
  • 19. Springer D, Jiskra J, Limanova Z, Zima T, Potlukova E. Thyroid in pregnancy: From physiology to screening. Crit Rev Clin Lab Sci. 2017;54:102-16. [CrossRef]
  • 20. Jia M, Wu Y, Lin B, et al. Meta-analysis of the association between maternal subclinical hypothyroidism and gestational diabetes mellitus. Int J Gynaecol Obstet. 2019;144:239-47. [CrossRef]
  • 21. Murgia C, Orru M, Portoghese E et al. Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report. Reprod Biol Endocrinol. 2008;6:24. [CrossRef]
  • 22. Olivieri A, Valensise H, Magnani F, et al. High frequency of anti-thyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol. 2000;143:741-7. [CrossRef]
  • 23. Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97:4464-72. [CrossRef]
  • 24. Ying H, Tang YP, Bao YR, et al. Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine. 2016;54:742-50. [CrossRef]
  • 25. Safian S, Esna-Ashari F, Borzouei S. Thyroid dysfunction in pregnant women with gestational diabetes mellitus. Curr Diabetes Rev. 2020;16(8):895-9. [CrossRef]
  • 26. Deng S-Q, Chen H-T, Wang D-Y, Liu B, Chen H-Q, Wang Z-L. Maternal Thyroid-Stimulating Hormone Level and Thyroid Peroxidase Antibody Status in the First and Second Trimester of Pregnancy and Their Relationship with the Risk of Gestational Diabetes Mellitus. Maternal-Fetal Medicine. 2019;1:81-5. [CrossRef]
  • 27. Yang Y, Li Q, Wang Q, Ma X. Thyroid antibodies and gestational diabetes mellitus: a meta-analysis. Fertil Steril. 2015;104:665-71 e3. [CrossRef]
  • 28. Hornnes PJ, Rasmussen N, Hegedus L, Kuhl C, Bottazzo GF. Glucose tolerance and incidence of pancreatic islet cell antibodies in pregnancy in women with thyroid autoantibodies. Horm Metab Res. 1991;23:122-5. [CrossRef]
  • 29. Fernandez-Soto L, Gonzalez A, Lobon JA, Lopez JA, Peterson CM, Escobar-Jimenez F. Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care. 1997;20:1524-8. [CrossRef]
  • 30. Montaner P, Juan L, Campos R, Gil L, Corcoy R. Is thyroid autoimmunity associated with gestational diabetes mellitus? Metabolism. 2008;57:522-5. [CrossRef]
  • 31. Agarwal MM, Dhatt GS, Punnose J, Bishawi B, Zayed R. Thyroid function abnormalities and anti-thyroid antibody prevalence in pregnant women at high risk for gestational diabetes mellitus. Gynecol Endocrinol. 2006;22:261-6. [CrossRef]
  • 32. World Health Organisation, UNICEF, ICCIDD. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers 2008. Geneva: 2007. Available from: https://apps.who.int/iris/bitstream/handle/10665/43781/9789241595827_eng.pdf ;jsessionid=64F4F47B3881756D261848E756695EBB?se quence=1
  • 33. Gowachirapant S, Jaiswal N, Melse-Boonstra A. et al. Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2017;5:853-63. [CrossRef]
  • 34. Koyuncu K, Turgay B, Soylemez F. Iodine deficiency in pregnant women at first trimester in Ankara. J Turk Ger Gynecol Assoc. 2019;20:37-40. [CrossRef]
  • 35. Vitkova H, Anderlova K, Radimerska V, Kratky J, Fait T, Jiskra J. Urinary iodine concentrations in pregnant women with gestational and pregestational diabetes mellitus. 17th European Congress of Endocrinology; 2015: BioScientifica. [CrossRef]
APA sert U, BÜYÜK G, Engin-Ustun Y, Ozgu-Erdinc A (2020). Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. , 195 - 201. 10.5222/MMJ.2020.29964
Chicago sert Umit yasemin,BÜYÜK Gül Nihal,Engin-Ustun Yaprak,Ozgu-Erdinc A. Seval Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. (2020): 195 - 201. 10.5222/MMJ.2020.29964
MLA sert Umit yasemin,BÜYÜK Gül Nihal,Engin-Ustun Yaprak,Ozgu-Erdinc A. Seval Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. , 2020, ss.195 - 201. 10.5222/MMJ.2020.29964
AMA sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. . 2020; 195 - 201. 10.5222/MMJ.2020.29964
Vancouver sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. . 2020; 195 - 201. 10.5222/MMJ.2020.29964
IEEE sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A "Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?." , ss.195 - 201, 2020. 10.5222/MMJ.2020.29964
ISNAD sert, Umit yasemin vd. "Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?". (2020), 195-201. https://doi.org/10.5222/MMJ.2020.29964
APA sert U, BÜYÜK G, Engin-Ustun Y, Ozgu-Erdinc A (2020). Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. Medeniyet Medical Journal, 35(3), 195 - 201. 10.5222/MMJ.2020.29964
Chicago sert Umit yasemin,BÜYÜK Gül Nihal,Engin-Ustun Yaprak,Ozgu-Erdinc A. Seval Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. Medeniyet Medical Journal 35, no.3 (2020): 195 - 201. 10.5222/MMJ.2020.29964
MLA sert Umit yasemin,BÜYÜK Gül Nihal,Engin-Ustun Yaprak,Ozgu-Erdinc A. Seval Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. Medeniyet Medical Journal, vol.35, no.3, 2020, ss.195 - 201. 10.5222/MMJ.2020.29964
AMA sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. Medeniyet Medical Journal. 2020; 35(3): 195 - 201. 10.5222/MMJ.2020.29964
Vancouver sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?. Medeniyet Medical Journal. 2020; 35(3): 195 - 201. 10.5222/MMJ.2020.29964
IEEE sert U,BÜYÜK G,Engin-Ustun Y,Ozgu-Erdinc A "Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?." Medeniyet Medical Journal, 35, ss.195 - 201, 2020. 10.5222/MMJ.2020.29964
ISNAD sert, Umit yasemin vd. "Is There Any Relationship Between Thyroid Function Abnormalities, Thyroid Antibodies and Development of Gestational Diabetes Mellitus (GDM) in Pregnant Women?". Medeniyet Medical Journal 35/3 (2020), 195-201. https://doi.org/10.5222/MMJ.2020.29964